S100A8 and S100A9 in human arterial wall - Implications for atherogenesis

被引:157
|
作者
McCormick, MM
Rahimi, F
Bobryshev, YV
Gaus, K
Zreiqat, H
Cai, H
Lord, RSA
Geczy, CL [1 ]
机构
[1] Univ New S Wales, Sch Med Sci, Inflammatory Dis Res Unit, Sydney, NSW 2052, Australia
[2] Univ New S Wales, Professorial Surg Unit, St Vincent Hosp, Sydney, NSW 2052, Australia
关键词
D O I
10.1074/jbc.M509442200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Atherogenesis is a complex process involving inflammation. S100A8 and S100A9, the Ca2+-binding neutrophil cytosolic proteins, are associated with innate immunity and regulate processes leading to leukocyte adhesion and transmigration. In neutrophils and monocytes the S100A8-S100A9 complex regulates phosphorylation, NADPH-oxidase activity, and fatty acid transport. The proteins have anti-microbial properties, and S100A8 may play a role in oxidant defense in inflammation. Murine S100A8 is regulated by inflammatory mediators and recruits macrophages with a proatherogenic phenotype. S100A9 but not S100A8 was found in macrophages in ApoE(-/-) murine atherosclerotic lesions, whereas both proteins are expressed in human giant cell arteritis. Here we demonstrate S100A8 and S100A9 protein and mRNA in macrophages, foam cells, and neovessels in human atheroma. Monomeric and complexed forms were detected in plaque extracts. S100A9 was strongly expressed in calcifying areas and the surrounding extracellular matrix. Vascular matrix vesicles contain high levels of Ca2+-binding proteins and phospholipids that regulate calcification. Matrix vesicles characterized by electron microscopy, x-ray microanalysis, nucleoside triphosphate pyrophosphohydrolase assay and cholesterol/phospholipid analysis contained predominantly S100A9. We propose that S100A9 associated with lipid structures in matrix vesicles may influence phospholipid-Ca2+ binding properties to promote dystrophic calcification. S100A8 and S100A9 were more sensitive to hypochlorite oxidation than albumin or low density lipoprotein and immunoaffinity confirmed S100A8-S100A9 complexes; some were resistant to reduction, suggesting that hypochlorite may contribute to protein cross-linking. S100A8 and S100A9 in atherosclerotic plaque and calcifying matrix vesicles may significantly influence redox- and Ca2+-dependent processes during atherogenesis and its chronic complications, particularly dystrophic calcification.
引用
收藏
页码:41521 / 41529
页数:9
相关论文
共 50 条
  • [41] S100A8 and S100A9 in Hematologic Malignancies: From Development to Therapy
    Razmkhah, Farnaz
    Kim, Sena
    Lim, Sora
    Dania, Abdul-Jalil
    Choi, Jaebok
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (17)
  • [42] Identification of S100A8 and S100A9 as Serological Markers for Colorectal Cancer
    Kim, Hye-Jung
    Kang, Hyun Ju
    Lee, Hanna
    Lee, Seung-Taek
    Yu, Myeong-Hee
    Kim, Hoguen
    Lee, Cheoju
    JOURNAL OF PROTEOME RESEARCH, 2009, 8 (03) : 1368 - 1379
  • [43] There is loss of expression of S100A8 and S100A9 in oesophageal squamous carcinoma
    Clarke, LC
    Rehman, I
    Leiblich, A
    Bury, JP
    Ackroyd, R
    Stoddard, CJ
    Wyman, A
    Harrison, RF
    Hamdy, FC
    Cross, SS
    JOURNAL OF PATHOLOGY, 2005, 207 : 49 - 49
  • [44] Significance of S100A8, S100A9 and calprotectin levels in bladder cancer
    Yasar, O.
    Akcay, T.
    Obek, C.
    Turegun, F. A.
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2017, 77 (06): : 437 - 441
  • [45] S100A8, S100A9 and the S100A8/A9 heterodimer complex specifically bind to human endothelial cells:: identification and characterization of ligands for the myeloid-related proteins S100A9 and S100A8/A9 on human dermal microvascular endothelial cell line-1 cells
    Eue, I
    König, S
    Pior, J
    Sorg, C
    INTERNATIONAL IMMUNOLOGY, 2002, 14 (03) : 287 - 297
  • [46] Roles of S100A8, S100A9 and S100A12 in infection, inflammation and immunity
    Xia, Pengpeng
    Ji, Xingduo
    Yan, Li
    Lian, Siqi
    Chen, Ziyue
    Luo, Yi
    IMMUNOLOGY, 2024, 171 (03) : 365 - 376
  • [47] S100A8, S100A9 and S100A8/A9 heterodimer as novel cachexigenic factors for pancreatic cancer-induced cachexia
    Liao, Wei-Chih
    Chen, Chih-Ta
    Tsai, You-Shu
    Wang, Xin-Ya
    Chang, Yen-Tzu
    Wu, Ming-Shiang
    Chow, Lu-Ping
    BMC CANCER, 2023, 23 (01)
  • [48] S100A8, S100A9 and S100A8/A9 heterodimer as novel cachexigenic factors for pancreatic cancer-induced cachexia
    Wei-Chih Liao
    Chih-Ta Chen
    You-Shu Tsai
    Xin-Ya Wang
    Yen-Tzu Chang
    Ming-Shiang Wu
    Lu-Ping Chow
    BMC Cancer, 23
  • [49] Effect of S100A8 and S100A9 on expressions of cytokine and skin barrier protein in human keratinocytes
    Kim, Mun Jeong
    Im, Mi Ae
    Lee, Ji-Sook
    Mun, Ji Young
    Kim, Da Hye
    Gu, Ayoung
    Kim, In Sik
    MOLECULAR MEDICINE REPORTS, 2019, 20 (03) : 2476 - 2483
  • [50] S100A8 AND S100A9 INDUCE A CATABOLIC SHIFT IN CHONDROCYTES FROM HUMAN OSTEOARTHRITIS PATIENTS
    Schelbergen, R. F. P.
    Blom, A. B.
    Sloetjes, A.
    Vogl, T.
    Roth, J.
    van den Berg, W. B.
    van Lent, P. L. E. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 : A83 - A83